Director · AbCellera Biologics Inc. · AbCellera Biologics Inc. — Share option (right to buy)
Side
A
Value
—
Shares
194.9K
Price
—
Executed
Dec 1, 2025
Disclosed
Dec 19, 2025
Disclosure timeline18 days from execution to publication · legal deadline 2 business days
Dec 1 executedDec 19, 2025 disclosed
ABCL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+10 / 15
Disclosed 14 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
AbCellera Biologics Inc. — Share option (right to buy)
Ticker
ABCL
Shares
194.9K
Price per share
$0
Execution date (reported)
Dec 1, 2025
Owned after transaction
194.9K shares
Days from execution to publication
18
What this establishes
Quake Stephen filed this Form 4 reporting a grant or award of ABCL on Dec 1, 2025. It became public on Dec 19, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Quake Stephencik:0001685889
Issuer
AbCellera Biologics Inc.cik:0001703057
Revision history · 0
No field has changed since this record was first ingested.
